Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
8.845 EUR | -3.70% | -13.88% | -58.44% |
May. 23 | EVOTEC : Deutsche Bank maintains a Buy rating | ZD |
May. 22 | Evotec Shares Rise Following Gene Therapy Exit, Q1 Results | MT |
Sales 2024 * | 882M 955M | Sales 2025 * | 1.03B 1.12B | Capitalization | 1.63B 1.76B |
---|---|---|---|---|---|
Net income 2024 * | -34M -36.79M | Net income 2025 * | 31M 33.55M | EV / Sales 2024 * | 2.16 x |
Net Debt 2024 * | 278M 301M | Net Debt 2025 * | 235M 254M | EV / Sales 2025 * | 1.8 x |
P/E ratio 2024 * |
-39.5
x | P/E ratio 2025 * |
35
x | Employees | 5,061 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 90.64% |
Latest transcript on Evotec SE
1 day | -1.58% | ||
1 week | -7.48% | ||
Current month | -7.29% | ||
1 month | -6.33% | ||
3 months | -34.99% | ||
6 months | -51.98% | ||
Current year | -57.57% |
Managers | Title | Age | Since |
---|---|---|---|
Mario Polywka
CEO | Chief Executive Officer | 61 | 19-06-18 |
Laetitia Rouxel
DFI | Director of Finance/CFO | 51 | 23-02-06 |
Craig Johnstone
COO | Chief Operating Officer | 54 | 12-04-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Mario Polywka
CEO | Chief Executive Officer | 61 | 19-06-18 |
Roland Sackers
BRD | Director/Board Member | 56 | 19-06-18 |
Chairman | 63 | 14-06-16 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
2.68% | 17 M€ | -.--% | - | |
2.59% | 202 M€ | -.--% | ||
0.21% | 79 M€ | -.--% | ||
0.15% | 2 M€ | -.--% |
Date | Price | Change | Volume |
---|---|---|---|
24-05-24 | 8.845 | -3.70% | 1,961,581 |
24-05-23 | 9.185 | -4.37% | 2,045,070 |
24-05-22 | 9.605 | +0.68% | 2,395,506 |
24-05-21 | 9.54 | -1.50% | 1,353,441 |
24-05-20 | 9.685 | -0.77% | 796,918 |
Delayed Quote Xetra, May 24, 2024 at 04:25 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-57.57% | 1.76B | |
+64.92% | 62.86B | |
-1.85% | 41.38B | |
+46.11% | 40.38B | |
-8.93% | 27.64B | |
+13.05% | 26.46B | |
-21.96% | 18.9B | |
+4.21% | 12.67B | |
+25.74% | 12.27B | |
+27.42% | 12.07B |
- Stock Market
- Equities
- EVT Stock